CLDI
Price:
$1.54
Market Cap:
$11.04M
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which ar...[Read more]
Industry
Biotechnology
IPO Date
2021-11-01
Stock Exchange
AMEX
Ticker
CLDI
According to Calidi Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 4.28. This represents a change of -1028.15% compared to the average of -0.46 of the last 4 quarters.
The mean historical PE Ratio of Calidi Biotherapeutics, Inc. over the last ten years is -94.20. The current 4.28 PE Ratio has changed -554.36% with respect to the historical average. Over the past ten years (40 quarters), CLDI's PE Ratio was at its highest in in the March 2022 quarter at 48.42. The PE Ratio was at its lowest in in the June 2021 quarter at -7001.26.
Average
-94.20
Median
-3.39
Minimum
-440.67
Maximum
-0.41
Discovering the peaks and valleys of Calidi Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.41
Minimum Annual Increase = -94.17%
Minimum Annual PE Ratio = -440.67
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.41 | -50.05% |
| 2023 | -0.83 | -75.53% |
| 2022 | -3.39 | -86.81% |
| 2021 | -25.69 | -94.17% |
The current PE Ratio of Calidi Biotherapeutics, Inc. (CLDI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.54
5-year avg
-94.20
10-year avg
-94.20
Calidi Biotherapeutics, Inc.’s PE Ratio is greater than Clearmind Medicine Inc. (-0.14), greater than Can-Fite BioPharma Ltd. (-1.20), greater than Kazia Therapeutics Limited (-0.74), greater than Titan Pharmaceuticals, Inc. (-1.27), greater than Silo Pharma, Inc. (-0.83), greater than CNS Pharmaceuticals, Inc. (-0.02), greater than 60 Degrees Pharmaceuticals, Inc. (-0.45), greater than Xenetic Biosciences, Inc. (-1.24), greater than Qualigen Therapeutics, Inc. (-0.23), greater than Soligenix, Inc. (-0.50),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.14 | $722.23K | |
| -1.20 | $3.65M | |
| -0.74 | $21.67M | |
| -1.27 | $4.44M | |
| -0.83 | $3.59M | |
| -0.02 | $3.74M | |
| -0.45 | $3.16M | |
| -1.24 | $3.92M | |
| -0.23 | $5.43M | |
| -0.50 | $16.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calidi Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Calidi Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Calidi Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Calidi Biotherapeutics, Inc. (CLDI)?
What is the highest PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?
What is the 3-year average PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?
What is the 5-year average PE Ratio for Calidi Biotherapeutics, Inc. (CLDI)?
How does the current PE Ratio for Calidi Biotherapeutics, Inc. (CLDI) compare to its historical average?